Liraglutide

Product Details

CasNo： 204656-20-2

MF： C172H265N43O51

Appearance： White powder

Delivery Time： 3 days

Packing： 1g/tube, 1kg/bag

Annual production capacity： Annual production capacity: 100 tons

Purity： 0.99

Application： Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) analog with 97% sequence homology to native human GLP-1. By activating GLP-1 receptors, it stimulates insulin secretion and suppresses glucagon release in a glucose-dependent manner; simultaneously delays gastric emptying and centrally suppresses appetite, thereby achieving excellent glycemic control and significant weight reduction. As an established metabolic disease therapeutic, it is primarily used in type 2 diabetes treatment, obesity management, and cardiovascular risk control areas.